As per Barclays, the US administration announced numerous executive orders with reforms associated with world trade, ...

S&P Global expects inflation to remain closer to 3.0% in 2025 as tariffs result in higher prices along the domestic supply ...

As the company drives leverage from its scale and witnesses benefits from AI-related efficiency initiatives, it delivered profitable growth. For Q3 2025, Palo Alto Networks, Inc. (NASDAQ ...

With businesses seeking AI-powered solutions in a bid to improve efficiency and decision-making, ServiceNow, Inc. (NYSE:NOW)’s expanded AI capabilities can fuel strong growth and market share gains.

While this opportunity is early, the unconstrained nature of performance advertising provides upside to both the magnitude and duration of growth that AppLovin could sustain if successful.” ...

This adaptability and innovation can fuel revenue growth, says Ikeda. Furthermore, the analyst highlighted the promising growth potential of Datadog, Inc. (NASDAQ:DDOG)’s Flex Logs, which ...

The analyst’s rating is backed by a combination of factors demonstrating the company’s growth potential and market position. As per the analyst, looking ahead, the potential market for ...

As one of the best pharmaceutical stocks focused on innovative pain therapies, Pacira is positioning itself for long-term growth. While SG&A expenses increased due to investments in commercial and ...

AbbVie Inc. (NYSE:ABBV) is a research-based pharmaceutical company that develops and sells products to treat chronic diseases in oncology, gastroenterology, rheumatology, dermatology, virology ...

Here is what the fund said: “Two software stocks that the Fund did not own, Palantir Technologies Inc. (NASDAQ:PLTR) and AppLovin Corporation, each gained more than 100% and accounted for 52% ...

the long-term outlook for GARDASIL 9 remains promising. Meanwhile, the company’s $27 billion Keytruda cancer juggernaut continues to grow at a healthy clip, powering earnings growth.” ...

Bristol-Myers Squibb Company (NYSE:BMY) is a biopharmaceutical company that discovers, develops, and delivers advanced medicines for serious diseases. Numerous therapeutic classes, such as ...